Trial Profile
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of MEDI3414 in Adults.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs MEDI 3414 (Primary) ; Influenza A virus H1N1 vaccines
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- 02 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Oct 2009 Data, including that from this trial, have been submitted to the US FDA, as reported by MedImmune.
- 22 Oct 2009 Interim results reported in a MedImmune media release.